PRLD – prelude therapeutics incorporated (US:NASDAQ)
Stock Stats
News
Several Insiders Invested In Prelude Therapeutics Flagging Positive News [Yahoo! Finance]
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting [Yahoo! Finance]
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
Prelude Therapeutics Incorporated (NASDAQ: PRLD) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $7.00 price target on the stock.
Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting [Yahoo! Finance]
Form ARS Prelude Therapeutics For: Dec 31
Form DEFA14A Prelude Therapeutics
Form DEF 14A Prelude Therapeutics For: Jun 14
Form 8-K Prelude Therapeutics For: Apr 08
Form 4 Prelude Therapeutics For: Apr 04 Filed by: Huang Jane
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.